Integra Lifesciences Holdings (IART) Cash from Investing Activities (2016 - 2026)
Integra Lifesciences Holdings' Cash from Investing Activities history spans 17 years, with the latest figure at -$34.9 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 721.53% to -$34.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$108.1 million, a 72.35% increase, with the full-year FY2025 number at -$108.1 million, up 72.35% from a year prior.
- Cash from Investing Activities hit -$34.9 million in Q4 2025 for Integra Lifesciences Holdings, down from -$15.6 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for IART hit a ceiling of $14.8 million in Q3 2022 and a floor of -$322.2 million in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$40.7 million across 5 years, with a median of -$15.6 million in 2023.
- Biggest five-year swings in Cash from Investing Activities: skyrocketed 274.69% in 2022 and later tumbled 1972.28% in 2024.
- Tracing IART's Cash from Investing Activities over 5 years: stood at -$27.5 million in 2021, then tumbled by 99.45% to -$54.8 million in 2022, then dropped by 4.39% to -$57.2 million in 2023, then soared by 92.58% to -$4.2 million in 2024, then tumbled by 721.53% to -$34.9 million in 2025.
- Business Quant data shows Cash from Investing Activities for IART at -$34.9 million in Q4 2025, -$15.6 million in Q3 2025, and -$21.6 million in Q2 2025.